BofA analyst Kevin Fischbeck upgraded Universal Health to Neutral from Underperform with a price target of $145, up from $120.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS:
BofA analyst Kevin Fischbeck upgraded Universal Health to Neutral from Underperform with a price target of $145, up from $120.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS: